|
1
|
Phinney DG and Prockop DJ: Concise review:
mesenchymal stem/multipotent stromal cells: the state of
transdifferentiation and modes of tissue repair - current views.
Stem Cells. 25:2896–2902. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
van Poll D, Parekkadan B, Cho CH,
Berthiaume F, Nahmias Y, Tilles AW and Yarmush ML: Mesenchymal stem
cell-derived molecules directly modulate hepatocellular death and
regeneration in vitro and in vivo. Hepatology. 47:1634–1643. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bassi EJ, Aita CA and Câmara NO: Immune
regulatory properties of multipotent mesenchymal stromal cells:
Where do we stand? World J Stem Cells. 3:1–8. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Han KH, Ro H, Hong JH, Lee EM, Cho B, Yeom
HJ, Kim MG, Oh KH, Ahn C and Yang J: Immunosuppressive mechanisms
of embryonic stem cells and mesenchymal stem cells in alloimmune
response. Transpl Immunol. 25:7–15. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Le Blanc K, Frassoni F, Ball L, et al:
Developmental Committee of the European Group for Blood and Marrow
Transplantation: Mesenchymal stem cells for treatment of
steroid-resistant, severe, acute graft-versus-host disease: A phase
II study. Lancet. 371:1579–1586. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vojtassák J, Danisovic L, Kubes M, Bakos
D, Jarábek L, Ulicná M and Blasko M: Autologous biograft and
mesenchymal stem cells in treatment of the diabetic foot. Neuro
Endocrinol Lett. 27(Suppl 2): 134–137. 2006.PubMed/NCBI
|
|
7
|
Guiducci S, Porta F, Saccardi R, et al:
Autologous mesenchymal stem cells foster revascularization of
ischemic limbs in systemic sclerosis: A case report. Ann Intern
Med. 153:650–654. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kharaziha P, Hellström PM, Noorinayer B,
et al: Improvement of liver function in liver cirrhosis patients
after autologous mesenchymal stem cell injection: A phase I-II
clinical trial. Eur J Gastroenterol Hepatol. 21:1199–1205. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun L, Wang D, Liang J, et al: Umbilical
cord mesenchymal stem cell transplantation in severe and refractory
systemic lupus erythematosus. Arthritis Rheum. 62:2467–2475. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Allison M: Genzyme backs Osiris, despite
Prochymal flop. Nat Biotechnol. 27:966–967. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Spaggiari GM, Capobianco A, Becchetti S,
Mingari MC and Moretta L: Mesenchymal stem cell-natural killer cell
interactions: Evidence that activated NK cells are capable of
killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell
proliferation. Blood. 107:1484–1490. 2006. View Article : Google Scholar
|
|
12
|
Nauta AJ, Westerhuis G, Kruisselbrink AB,
Lurvink EG, Willemze R and Fibbe WE: Donor-derived mesenchymal stem
cells are immunogenic in an allogeneic host and stimulate donor
graft rejection in a nonmyeloablative setting. Blood.
108:2114–2120. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Akira S, Uematsu S and Takeuchi O:
Pathogen recognition and innate immunity. Cell. 124:783–801. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Blasius AL and Beutler B: Intracellular
Toll-like receptors. Immunity. 32:305–315. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang T, Town T, Alexopoulou L, Anderson
JF, Fikrig E and Flavell RA: Toll-like receptor 3 mediates West
Nile virus entry into the brain causing lethal encephalitis. Nat
Med. 10:1366–1373. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ghosh TK, Mickelson DJ, Solberg JC, Lipson
KE, Inglefield JR and Alkan SS: TLR-TLR cross talk in human PBMC
resulting in synergistic and antagonistic regulation of type-1 and
2 interferons, IL-12 and TNF-α. Int Immunopharmacol. 7:1111–1121.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lombardo E, DelaRosa O, Mancheño-Corvo P,
Menta R, Ramírez C and Büscher D: Toll-like receptor-mediated
signaling in human adipose-derived stem cells: Implications for
immunogenicity and immunosuppressive potential. Tissue Eng Part A.
15:1579–1589. 2009. View Article : Google Scholar
|
|
18
|
Opitz CA, Litzenburger UM, Lutz C, et al:
Toll-like receptor engagement enhances the immunosuppressive
properties of human bone marrow-derived mesenchymal stem cells by
inducing indoleamine-2,3-dioxygenase-1 via interferon-beta and
protein kinase R. Stem Cells. 27:909–919. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Miranda HC, Herai RH, Thomé CH, Gomes GG,
Panepucci RA, Orellana MD, Covas DT, Muotri AR, Greene LJ and Faça
VM: A quantitative proteomic and transcriptomic comparison of human
mesenchymal stem cells from bone marrow and umbilical cord vein.
Proteomics. 12:2607–2617. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hsieh JY, Wang HW, Chang SJ, Liao KH, Lee
IH, Lin WS, Wu CH, Lin WY and Cheng SM: Mesenchymal stem cells from
human umbilical cord express preferentially secreted factors
related to neuroprotection, neurogenesis, and angiogenesis. PLoS
One. 8:e726042013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fu YS, Cheng YC, Lin MY, Cheng H, Chu PM,
Chou SC, Shih YH, Ko MH and Sung MS: Conversion of human umbilical
cord mesenchymal stem cells in Wharton’s jelly to dopaminergic
neurons in vitro: Potential therapeutic application for
Parkinsonism. Stem Cells. 24:115–124. 2006. View Article : Google Scholar
|
|
22
|
Shi M, Liu ZW and Wang FS:
Immunomodulatory properties and therapeutic application of
mesenchymal stem cells. Clin Exp Immunol. 164:1–8. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li Y and Lin F: Mesenchymal stem cells are
injured by complement after their contact with serum. Blood.
120:3436–3443. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tomchuck SL, Zwezdaryk KJ, Coffelt SB,
Waterman RS, Danka ES and Scandurro AB: Toll-like receptors on
human mesenchymal stem cells drive their migration and
immunomodulating responses. Stem Cells. 26:99–107. 2008. View Article : Google Scholar
|
|
25
|
Huang YC, Parolini O, La Rocca G and Deng
L: Umbilical cod versus bone marrow-derived mesenchymal stromal
cells. Stem Cells Dev. 21:2900–2903. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
DelaRosa O and Lombardo E: Modulation of
adult mesenchymal stem cells activity by Toll-like receptors:
Implications on therapeutic potential. Mediators Inflamm.
2010:8656012010.PubMed/NCBI
|
